NASDAQ · TXN

Texas Instruments Incorporated

$279.41 -$0.17 (-0.06%) 1D Pre-market

Key Metrics

$255.28B
Market cap
47.57×
P/E · TTM
$18.44B
Revenue · TTM
$5.37B
Net income
EPS · TTM $5.86
Dividend yield 2.0%
Free cash flow $3.72B
Beta · 1Y 1.32
EBITDA · TTM $8.18B
Gross margin 57.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 26
    The stock moved -8.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 26
  • Apr 23
    The stock moved +19.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 23

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$255.28B
Enterprise value$264.21B
Shares outstanding913.1M
52-wk range$152.73 – $334.03
Avg volume · 20D5.8M
Net cash −$8.93B
Book value / share$18.32
IndustrySemiconductors & Related Devices
ExchangeNASDAQ
About Texas Instruments Incorporated
IPO dateOct 1, 1953
Employees33000

Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E47.57
P/S13.85
P/FCF68.61
EV/EBITDA32.29
EV/Sales14.33
Graham №$49.14

Profitability

Gross 57.3%
Operating 33.3%
Net 29.1%
FCF 20.2%
ROE / ROIC 31.9% · 20.9%

Financial Health

Current ratio4.46
Quick ratio2.94
Debt / equity0.84
Debt / EBITDA 1.72
Net cash −$8.93B
Working capital$10.70B

Cash Flow · TTM

Operating CF $7.82B
Capex −$4.10B
Free cash flow $3.72B
Buybacks $982.00M
Dividends paid $5.05B
Shareholder yield 2.4%

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

12.3
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$49.14 vs $279.41
Trades 5.7× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings